Drug intelligence / Profile preview

Venalar 500

Development stage
Unknown
Lead developer
Diod
Modality
Small Molecules
Administration
Oral
01

Overview

Venalar 500 is a dietary supplement (БАД) developed and manufactured by the Russian company Diod, specifically formulated to support venous health and address venous circulation disorders. It contains a micronized flavonoid fraction consisting of 450 mg of diosmin and 50 mg of hesperidin. The supplement acts as a venotonic and angioprotective agent; it increases venous tone by prolonging the activity of norepinephrine on the vessel wall, improves lymphatic drainage, and reduces capillary permeability and inflammation. It is commonly used to alleviate symptoms of chronic venous insufficiency, such as leg heaviness, pain, and nocturnal cramps, as well as for the symptomatic treatment of hemorrhoids. As a dietary supplement, it is not classified as a pharmaceutical medicinal product in Russia.

Brand names
Venalar 500Venalar500Venalar-500Веналар 500
Other names
VenalarВеналар
02

Targets

CYSLTR1 (Cysteinyl-leukotriene type 1 receptor)

Beyond the preview

Go deeper on Venalar 500.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Venalar 500.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call